The Bottom Line
GlaxoSmithKline, Europe’s largest drugmaker, named 43-year-old Briton Andrew Witty as its new chief executive.
A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
GlaxoSmithKline, Europe’s largest drugmaker, named 43-year-old Briton Andrew Witty as its new chief executive. Witty takes the helm from Frenchman Jean-Pierre Garnier next May. “He has the luxury of time, since he could be there for the best part of 20 years,” said analyst Peter Cartwright at Evolution Securities. (Reuters)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
6 new horror novels to read this fall
These upcoming releases will have you on the edge of your seat — or hiding under the covers
By David Faris Published
-
6 bucolic homes in New Hampshire
Feature Featuring an island house in Meredith and a private pond in Lee
By The Week Staff Published
-
Etaf Rum recommends 6 empowering reads centered around women
Feature The author suggests works by Zora Neale Hurston, Sylvia Plath and more
By The Week Staff Published